ELTHERA
Elthera AG is a Swiss biopharmaceutical start-up company bringing together experienced pharma and biotech executives with cutting-edge academic researchers to develop proprietary, first-in-class oncology drugs using a personalized health care approach.
ELTHERA
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.elthera.com
Total Employee:
1+
Status:
Active
Contact:
+41 79 771 25 35
Total Funding:
2.81 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - Elthera
Penny Schiffer
Penny Schiffer investment in Series A - Elthera
GoBeyond
GoBeyond investment in Series A - Elthera
Official Site Inspections
http://www.elthera.com Semrush global rank: 5.19 M Semrush visits lastest month: 1.56 K
- Host name: dd32038.kasserver.com
- IP address: 85.13.149.188
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Elthera"
Swiss Biopharmaceutical company - Elthera AG
Elthera AG is a Swiss biopharmaceutical company founded in 2016 by experienced Pharma and Biotech executives with the goal of developing proprietary, first-in-class oncology drugs using a personalized health care …See details»
Elthera - Crunchbase Company Profile & Funding
Elthera is developing an immunotherapy targeting L1CAM to activate the immune system against cancer cells, aiming to halt tumor progression. Companion Diagnostics Elthera collaborates …See details»
Elthera AG - LinkedIn
Elthera AG is a Swiss biopharmaceutical start-up company bringing together experienced pharma and biotech executives with cutting-edge academic researchers to develop proprietary, first-in …See details»
Elthera AG - Swiss Biotech
Elthera AG . Swiss Biotech Association. Member. Profile News, events, jobs ... Type of organization. Private company. Year of foundation. 2016. Number of employees in …See details»
Elthera - Funding, Financials, Valuation & Investors - Crunchbase
Elthera AG is a Swiss biopharmaceutical start-up company bringing together experienced pharma and biotech executives. New. Resources. Advanced Search. ... How much funding has this …See details»
Elthera AG - VentureRadar
Elthera AG is a Swiss biopharmaceutical start-up company bringing together experienced pharma and biotech executives with cutting-edge academic researchers to develop proprietary, first-in …See details»
Elthera - Contacts, Employees, Board Members, Advisors & Alumni
Elthera AG is a Swiss biopharmaceutical start-up company bringing together experienced pharma and biotech executives. ... Experience the new Crunchbase, powered by AI . Organization. …See details»
Elthera AG | S-GE
Switzerland Global Enterprise is the official Swiss organization for export and investment promotion. As a private consulting and platform organization commissioned by the …See details»
Elthera AG, Schlieren - business-monitor.ch
Elthera AG, company active in "Research and experimental development on biotechnology" - Commerce registry, network, industry, decision-makers and contacts, SOGCSee details»
Elthera AG - Schlieren, Switzerland - bionity.com
Elthera AG is developing antibodies against the novel target L1CAM, an adhesion molecule whose expression is strongly correlated with an aggressive tumor phenotype and poor …See details»
Elthera AG - Drug pipelines, Patents, Clinical trials - Synapse
Elthera has received funding from the European Union's Horizon 2020 research and innovation programme under the grant agreement No 858753 and co-funding by the Innosuisse-Swiss Innovation Agency and the European Union under the Eurostars project E!114014 ... The statistics for drugs in the Pipeline is the current organization and its ...See details»
Elthera 2025 Company Profile: Valuation, Funding & Investors
Elthera General Information Description. Developer of oncology drugs designed to offer treatment for cancer. The company's clinical candidate compound has demonstrated efficacy in several …See details»
Elthera Company Profile - Office Locations, Competitors ... - Craft
Elthera has 5 employees at their 1 location. See insights on Elthera including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Data Protection - Elthera
Data protection. Responsible body in terms of data protection laws, in particular the EU General Data Protection Regulation (GDPR): Elthera AG Anne SchmidtSee details»
Elthera | Qualifyze
Elthera AG, a biopharmaceutical organization based in Switzerland, was established in 2016 by seasoned Pharma and Biotech professionals with the aim of creating innovative oncology …See details»
Elthera AG - Venturelab
Feb 16, 2016 Elthera AG is developing antibodies against the novel target L1CAM, an adhesion molecule whose expression is strongly correlated with an aggressive tumor phenotype and …See details»
Elthera AG - top100startup.ch
Oct 16, 2020 News. 14.02.2023 South Korean Biotech acquires first-in-class antibody from Elthera (startupticker.ch); 17.11.2020 Sino-Swiss Pitchinar – Venture Leaders China meet …See details»
Meet Elthera CEO Anne Schmidt and find out how she went back …
Oct 16, 2020 Venture Leader China Anne Schmidt co-founded Elthera, a biotech startup that develops immunotherapy directed against the L1CAM gene, which harnesses the patient’s …See details»
News - Elthera
Meet Elthera at: BIO-Europe Spring 22ND - 25TH MARCH 2021 | Digital Conference More InfoSee details»
Elthera - Alien Technology Transfer | Alien Technology Transfer
The EU-funded Anti-L1CAM project plans to bring their antibody against L1CAM to market, due to its efficacy as an anti-cancer therapy.See details»